image image image image image image
The hands down leader in bone density screening.
image image
image

For Doctors

Bone Health Issues: Are Your Patients at Risk?

Osteoporosis is a U.S. public health crisis: about 1 in 2 women and 1 in 4 men over 50 will suffer an osteoporosis-related fracture, yet many women have never been tested. One 2004 case-based study of osteoporosis and primary care noted that 75% of American women between the ages of 45 and 75 years had never discussed osteoporosis with their physician. People who suffer osteoporosis related fractures are more likely to have another fracture than people who do not, and they also have a higher mortality rate. There are no obvious symptoms of osteoporosis until someone suffers a fracture.

In the past, osteoporosis could not be easily diagnosed until a fracture occurred. Today with new screening technology, most people who are at risk can be identified before a fracture occurs. This allows them to start treatment programs or to implement lifestyle changes that can significantly reduce the risk of a first fracture, or the risk of further fractures if a fracture has already occurred.

Bone Density CPT code 77081 CPT

As of 2015 and for the foreseeable future, the same CPT code that has been used in the past is still being used for peripheral BMD measurements: 77081 is used to code axial bone like wrist, radius, heel, finger, Click here for more information. Type "CPT code 77081" in the search field for pertinent articles.

Every day, healthcare professionals face a fundamental challenge: how to provide widespread BMD screening for the population most at risk of suffering an osteoporosis-related fracture given that osteoporosis is an invisible disease obscured by limited public awareness. To ensure that accudxa2 users are being reimbursed, Lone Oak routinely reviews the Medicare website to ensure that many of our customers are being reimbursed. 2012 is the latest year available on the Medicare website and many accudxa2 users where listed.

In-Office DXA Screening: Raising the Standard of Care for the 21st Century

You may be aware of peripheral screening devices for in-office ultrasound fracture risk assessment using the heel, but did you know that instead, you could be providing a Dual Energy X-ray Absorptiometry (DXA) bone mineral density test in your office? A peripheral DXA screening of the middle finger using the accudxa2 Model 7200 BMD Assessment System takes a couple of minutes, is easy to perform, and is reimbursable by Medicare Part B at a higher rate than ultrasound of the calcaneus (as of 2014). Compare and learn more about reimbursement rates for peripheral DXA testing and peripheral ultrasound testing online from the Centers for Medicare and Medicaid Services’ Physician Fee Schedule Search tool (http://www.cms.gov/apps/physician-fee-schedule/license-agreement.aspx).

Who should be receiving a BMD Test?

According to the International Society for Clinical Densitometry (ISCD) , some of the key indications for BMD testing are:
  • Women aged 65 and older, or for post-menopausal women younger than age 65 with other risk factors for low bone mass such as low body weight or a prior fracture, high risk medication use (such as prolonged glucocorticoid steroid use)
  • Women during the menopausal transition with clinical risk factors for low bone mass, such as low body weight, a history of fractures, or high-risk medication use.
  • Men aged 70 and older, or men younger than 70 years of age with one or more risk factors for low bone mass including low body weight, history of fractures, high risk medication use or diseases or other conditions associated with bone loss.
This is not an exhaustive list of indications – for additional information, please consult the 2013 ISCD Official Positions – Adult, or the National Osteoporosis Foundation 2014 Clinician’s Guide to Prevention and Treatment of Osteoporosis: (http://nof.org/files/nof/public/content/file/2610/upload/895.pdf)

Learn More about the accudxa2® Model 7200 BMD Assessment System from Lone Oak Medical Technologies

Make the accudxa2® BMD Test Report part of your patient conversation about osteoporosis. Call Lone Oak Medical Technologies today at 1-888-818-4BMD – or email info@loneoakmedical.com - to learn more about how the accudxa2® BMD Assessment System can help you raise the standard of care for BMD screening in your office.
1 (Source: National Osteoporosis Foundation: Debunking the Myths http://nof.org/articles/4) 2 (Source: Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach, Gend Med. 2004 Dec;1(2):70-85) 3 (Source: Bone health and osteoporosis : a report of the Surgeon General. - Rockville, Md. : U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 2004 (468 pages on-line at http://www.ncbi.nlm.nih.gov/books/NBK45513/pdf/TOC.pdf) 4 (Source: 2013 ISCD Official Positions – Adult – online at http://www.iscd.org/official-positions/2013-iscd-official-positions-adult/) 5 (Source: National Osteoporosis Foundation 2014 Clinician’s Guide to Prevention and Treatment of Osteoporosis http://nof.org/files/nof/public/content/file/2610/upload/895.pdf)